新闻
- Launch of Distribution of RET-700(PDF)
- Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132(PDF)
- Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion(PDF)
- Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion(PDF)